FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chia-Yen Dai

Research Profile

Disorders

Geographic Areas

Taiwan

Living Beings

Chemicals & Drugs

Concepts & Ideas

Procedures

Drug Therapy, Combination

Physiology

Genotype

Co-author Network

Publications

TOP 3
Chung-Feng Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Jia-Horng Kao; Zu-Yau Lin; Tai-Chung Tseng; Liang-Yen Wang; Ming-Lun Yeh; Ming-Lung Yu; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Chen-Hua Liu
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.
Jee-Fu Huang; Ming-Lung Yu; Chia-Yen Dai; Wan-Long Chuang
Glucose abnormalities in hepatitis C virus infection.
Chung-Feng Huang; Ching-I Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Yi-Ching Lin; Zu-Yau Lin; Liang-Yen Wang; Ming-Lun Yeh; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Ming-Yen Hsieh; Ming-Lung Yu
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chia-Yen Dai (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chung-Feng Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Jia-Horng Kao; Zu-Yau Lin; Tai-Chung Tseng; Liang-Yen Wang; Ming-Lun Yeh; Ming-Lung Yu; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Chen-Hua Liu
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(4):293-8.
2013: Jee-Fu Huang; Ming-Lung Yu; Chia-Yen Dai; Wan-Long Chuang
Glucose abnormalities in hepatitis C virus infection.
The Kaohsiung journal of medical sciences 2013;29(2):61-8.
2013: Chung-Feng Huang; Ching-I Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Yi-Ching Lin; Zu-Yau Lin; Liang-Yen Wang; Ming-Lun Yeh; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Ming-Yen Hsieh; Ming-Lung Yu
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients.
PloS one 2013;8(3):e58882.
2012: Meng-Hsuan Hsieh; Chung-Feng Huang; Chao-Kuan Huang; Wen-Yi Lin; Chao-Ling Wang; Jeng-Fu Yang; Ming-Lung Yu; Ning-Chia Chang; Hsu-Han Chien; Li-Ho Chien; Wan-Long Chuang; Chia-Yen Dai; Chi-Kung Ho
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
The Kaohsiung journal of medical sciences 2012;28(9):470-6.
2012: Jee-Fu Huang; Suh-Hang Hank Juo; Zu-Yau Lin; Shyi-Jang Shin; Jeng-Fu Yang; Ming-Lun Yeh; Ming-Lung Yu; Chia-Yen Dai; Nei-Jen Hou; Meng-Hsuan Hsieh; Ming-Yen Hsieh; Chung-Feng Huang; Shinn-Chern Chen; Wan-Long Chuang
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(6):962-9.
2012: Ming-Yen Hsieh; Jee-Fu Huang; Li-Po Lee; Zu-Yau Lin; Liang-Yen Wang; Wen-Yu Chang; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Nai-Jen Hou; Ming-Yuh Hsieh; Ming-Lung Yu
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
The Kaohsiung journal of medical sciences 2012;28(2):86-93.
2012: Chung-Feng Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Zu-Yau Lin; Liang-Yen Wang; Jeng-Fu Yang; Ming-Lun Yeh; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Edward Hsi; Ming-Yen Hsieh; Ming-Lung Yu
Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1.
Antiviral research 2012;93(2):239-44.
2012: Ming-Lung Yu; Shinn-Cherng Chen; Wan-Long Chuang; Chia-Yen Dai; Chung-Feng Huang; Jee-Fu Huang; Suh-Hang Hank Juo; Zu-Yau Lin; Chen-Hua Liu; Tai-Chung Tseng; Liang-Yen Wang; Jia-Horng Kao
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
PloS one 2012;7(12):e52048.
2011: Jee-Fu Huang; Zu-Yau Lin; Shyi-Jang Shin; Jeng-Fu Yang; Ming-Lun Yeh; Ming-Lung Yu; Chia-Yen Dai; Nei-Jen Hou; Pi-Jung Hsiao; Chung-Feng Huang; Ching-I Huang; Shinn-Chern Chen; Wan-Long Chuang
Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(8):1155-62.
2011: Chia-Yen Dai; Chung-Feng Huang; Jee-Fu Huang; Wan-Long Chuang; Ming-Lung Yu
Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story.
Hepatology (Baltimore, Md.) 2011;53(5):1774-5; author reply 1775-6.
2011: Ku-Chung Chen; Yung-Song Wang; Ching-Yu Hu; Wei-Chiao Chang; Yi-Chu Liao; Chia-Yen Dai; Suh-Hang Hank Juo
OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(5):1718-28.
2011: Chia-Yen Dai; Ming-Lun Yeh; Jee-Fu Huang; Wan-Long Chuang; Ming-Lung Yu
Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier.
Hepatology (Baltimore, Md.) 2011;53(4):1399; author reply 1400.
2011: Jee-Fu Huang; Chung-Feng Huang; Ming-Lung Yu; Chia-Yen Dai; Ching-I Huang; Ming-Lun Yeh; Meng-Hsuan Hsieh; Jeng-Fu Yang; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Chern Chen; Wan-Long Chuang
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
Journal of gastroenterology and hepatology 2011;26(3):530-5.
2011: Jee-Fu Huang; Ming-Lung Yu; Chung-Feng Huang; Chang-Fu Chiu; Chia-Yen Dai; Ching-I Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ming-Yen Hsieh; Nei-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Liang-Yen Wang; Wan-Long Chuang
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
Journal of hepatology 2011;54(2):219-26.
2011: Ming-Lun Yeh; Ming-Lung Yu; Pei-Jer Chen; Wan-Long Chuang; Chia-Yen Dai; Tsung-Hui Hu; Jee-Fu Huang; Chao-Hung Hung; Jia-Horng Kao; Chuan-Mo Lee; Zu-Yau Lin; Chun-Jen Liu; Sheng-Nan Lu; Jing-Houng Wang; Ding-Shinn Chen
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
PloS one 2011;6(6):e20752.
2010: Chia-Yen Dai
Treatment uptake of patients with chronic hepatitis C: can we expect and do more?
Digestive diseases and sciences 2010;55(12):3300-3.
2010: Jeng-Fu Yang; Chia-I Lin; Jee-Fu Huang; Chia-Yen Dai; Wen-Yi Lin; Chi-Kung Ho; Ming-Yuh Hsieh; Li-Po Lee; Nai-Jen Ho; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu; Wan-Long Chuang; Wen-Yu Chang
Viral hepatitis infections in southern Taiwan: a multicenter community-based study.
The Kaohsiung journal of medical sciences 2010;26(9):461-9.
2010: Ming-Lung Yu; Chuan-Mo Lee; Wan-Long Chuang; Sheng-Nan Lu; Chia-Yen Dai; Jee-Fu Huang; Zu-Yau Lin; Tsung-Hui Hu; Chien-Hung Chen; Chao-Hung Hung; Jin-Houng Wang; Chi-Ling Chen; Jia-Horng Kao; Ming-Yang Lai; Chen-Hua Liu; Tung-Hung Su; Shun-Sheng Wu; Li-Ying Liao; Hsing-Tao Kuo; You-Chen Chao; Shui-Yi Tung; Sien-Sing Yang; Pei-Jer Chen; Chun-Jen Liu; Ding-Shinn Chen
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
The Journal of infectious diseases 2010;202(1):86-92.
2010: Chung-Feng Huang; Jeng-Fu Yang; Jee-Fu Huang; Chia-Yen Dai; Chang-Fu Chiu; Nai-Jen Hou; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response.
Journal of gastroenterology and hepatology 2010;25(4):758-65.
2010: Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang; Ming-Lung Yu
Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
Gut 2010;59(3):418.
2010: Chung-Feng Huang; Jeng-Fu Yang; Chia-Yen Dai; Jee-Fu Huang; Nai-Jen Hou; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.
The Journal of infectious diseases 2010;201(5):751-9.
2010: Chia-Yen Dai; Chi-Kung Ho; Jee-Fu Huang; Ming-Yuh Hsieh; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Ming-Lung Yu; Wan-Long Chuang
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.
Journal of hepatology 2010;52(2):160-6.
2010: Chia-Yen Dai; Wan-Long Chuang; Ming-Yuh Hsieh; Jee-Fu Huang; Ya-Yun Lin; Pei-Yu Chu; Nei-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.
Antiviral research 2010;85(2):396-402.
2009: Jeng-Fu Yang; Ya-Yun Lin; Jee-Fu Huang; Shu-Fen Liu; Pei-Yu Chu; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Liang-Yen Wang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients.
The Kaohsiung journal of medical sciences 2009;25(8):413-22.
2009: Jee-Fu Huang; Wan-Long Chuang; Ming-Lung Yu; Sung-Hua Yu; Chung-Feng Huang; Ching-I Huang; Ming-Li Yeh; Meng-Hsuan Hsieh; Jeng-Fu Yang; Zu-Yau Lin; Shinn-Chern Chen; Chia-Yen Dai; Wen-Yu Chang
Hepatitis C virus infection and metabolic syndrome---a community-based study in an endemic area of Taiwan.
The Kaohsiung journal of medical sciences 2009;25(6):299-305.
2009: Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns.
Hepatology (Baltimore, Md.) 2009;49(6):2125; author reply 2125-6.
2009: J-F Yang; M-Y Hsieh; N-J Hou; Chia-Yen Dai; J-F Huang; Z-Y Lin; S-C Chen; M-Y Hsieh; L-Y Wang; W-L Chuang; M-L Yu
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
Alimentary pharmacology & therapeutics 2009;29(9):1000-10.
2009: Chung-Feng Huang; Chia-Yen Dai; Wan-Long Chuang; Chi-Kung Ho; Ta-Chung Wu; Nai-Jen Hou; Chao-Ling Wang; Ming-Yuh Hsieh; Jee-Fu Huang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jun-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study.
Preventive medicine 2009;48(4):397-400.
2009: Ming-Lun Yeh; Jee-Fu Huang; Ming-Lung Yu; Chia-Yen Dai; Wan-Long Chuang
Unveiling glucose abnormalities in patients with chronic hepatitis C infection.
The American journal of gastroenterology 2009;104(4):1051; author reply 1052.
2009: Chia-Yen Dai; Jee-Fu Huang; Ming-Yuh Hsieh; Nei-Jen Hou; Zu-Yau Lin; Shinn-Chern Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
Journal of hepatology 2009;50(4):712-8.
2009: Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Shyi-Jang Shin; Ming-Yen Hsieh; Chung-Feng Huang; Li-Po Lee; Kun-Der Lin; Zu-Yau Lin; Shinn-Chern Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.
Journal of hepatology 2009;50(3):471-8.
2009: Ya-Yun Lin; Jee-Fu Huang; Shu-Fen Liu; Ming-Lung Yu; Chiu-Hung Tsai; Jeng-Fu Yang; I-Ling Lin; Chia-Yen Dai; Zu-Yau Lin; Shinn-Chern Chen; Wen-Yu Chang; Wan-Long Chuang
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.
Scandinavian journal of infectious diseases 2009;41(8):614-8.
2009: Ching-I Huang; Chia-Yen Dai; Jee-Fu Huang; Ming-Lung Yu
What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity.
Journal of hepatology 2009;50(1):212; author reply 213.
2008: Chia-Yen Dai; Wan-Long Chuang; Li-Po Lee; Wen-Cheng Pan; Jee-Fu Huang; Ming-Yen Hsieh; Nei-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Ming-Lung Yu
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.
Translational research : the journal of laboratory and clinical medicine 2008;152(4):151-6.
2008: Ta-Chung Wu; Wan-Long Chuang; Chia-Yen Dai; Jee-Fu Huang; Ming-Yuh Hsieh; Nai-Jen Hou; Li-Po Lee; Wen-Yi Lin; Jeng-Fu Yang; Chao-Chin Chiu; Shinn-Cherng Chen; Ming-Yuh Hsieh; Wen-Yu Chang; Ming-Lung Yu
Hepatitis C virus infection among children in aboriginal areas in Taiwan.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2008;102(9):935-8.
2008: Chung-Feng Huang; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Sheng-Nan Lu; Ming-Yuh Hsieh; Li-Po Lee; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2008;102(9):929-34.
2008: Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu
Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
Hepatology (Baltimore, Md.) 2008;48(2):692-3; author reply 693-4.
2008: Jee-Fu Huang; Ming-Lung Yu; Chia-Yen Dai; Ming-Yuh Hsieh; Shang-Jyh Hwang; Pi-Jung Hsiao; Li-Po Lee; Zu-Yau Lin; Shinn-Chern Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Shyi-Jang Shin; Wen-Yu Chang; Wan-Long Chuang
Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
The American journal of gastroenterology 2008;103(8):1933-40.
2008: Ying-Chu Lin; Hsin-I Huang; Li-Hsuan Wang; Chi-Cheng Tsai; Oliver Lung; Chia-Yen Dai; Ming-Lung Yu; Chi-Kung Ho; Chung-Ho Chen
Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Oral oncology 2008;44(8):798-804.
2008: Chia-Yen Dai; Wan-Long Chuang; Chi-Kung Ho; Ming-Yuh Hsieh; Jee-Fu Huang; Li-Po Lee; Nei-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study.
Journal of hepatology 2008;49(1):9-16.
2008: Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Chang-Fu Chiu; Yi-Hsin C Yang; Nei-Jen Hou; Li-Po Lee; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.
Hepatology (Baltimore, Md.) 2008;47(6):1884-93.
2008: Jen-Eing Jeng; Jung-Fa Tsai; Lea-Yea Chuang; Mei-Shang Ho; Zu-Yau Lin; Ming-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai; Tai-Heng Chen
Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study.
Medicine 2008;87(2):87-98.
2008: M-Y Hsieh; Chia-Yen Dai; Li-Po Lee; J-F Huang; W-C Tsai; N-J Hou; Zu-Yau Lin; Shinn-Cherng Chen; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Journal of clinical pathology 2008;61(3):333-7.
2008: Ming-Yen Heish; Chia-Yen Dai; Jee-Fu Huang; Li-Po Lee; Nei-Jen Hou; Wan-Long Chuang; Ming-Lung Yu
Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
The American journal of gastroenterology 2008;103(2):487-8; author reply 488.
2008: Jee-Fu Huang; Chia-Yen Dai; Ya-Yun Lin; Ming-Lung Yu; Shu-Fen Liu; I-Ling Lin; Ming-Yuh Hsieh; Li-Po Lee; Zu-Yau Lin; Shinn-Chern Chen; Ming-Yuh Hsieh; Wen-Yu Chang; Wan-Long Chuang
Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(4):475-80.
2007: Chia-Yen Dai; Ming-Lung Yu; Ming-Yen Hsieh; Li-Po Lee; Nei-Jen Hou; Jee-Fu Huang; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Wan-Long Chuang
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(10):1364-70.
2007: Meng-Hsuan Hsieh; Li-Po Lee; Ming-Yen Hsieh; Kun-Bow Tsai; Jee-Fu Huang; Nai-Jen Hou; Shinn-Chern Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
Japanese journal of infectious diseases 2007;60(6):377-81.
2007: Jen-Eing Jeng; Jung-Fa Tsai; Lea-Yea Chuang; Mei-Shang Ho; Zu-Yau Lin; Ming-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai; Jan-Gowth Chang
Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.
Neoplasia (New York, N.Y.) 2007;9(11):987-92.
2007: Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Li-Po Lee; Nai-Jen Hou; Ming-Lung Yu; Wan-Long Chuang
Links between triglyceride levels, hepatitis C virus infection and diabetes.
Gut 2007;56(8):1167-8.
2007: Chia-Yen Dai; Wan-Long Chuang; Ming-Yen Hsieh; Li-Po Lee; Jee-Fu Huang; Nei-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
Antiviral research 2007;75(2):146-51.
2007: Ming-Yuh Hsieh; Li-Po Lee; Nei-Jen Hou; Jeng-Fu Yang; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Ming-Lung Yu
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0.
The Kaohsiung journal of medical sciences 2007;23(7):332-8.
2007: Jee-Fu Huang; Chia-Yen Dai; Shang-Jyh Hwang; Chi-Kung Ho; Pi-Jung Hsiao; Ming-Yuh Hsieh; Li-Po Lee; Zu-Yau Lin; Shinn-Chern Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Shyi-Jang Shin; Wen-Yu Chang; Wan-Long Chuang; Ming-Lung Yu
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication.
The American journal of gastroenterology 2007;102(6):1237-43.
2007: Jee-Fu Huang; Ming-Yen Hsieh; Chia-Yen Dai; Nai-Jen Hou; Li-Po Lee; Zu-Yau Lin; Shinn-Chern Chen; Liang-Yen Wang; Ming-Yuh Hsieh; Wen-Yu Chang; Ming-Lung Yu; Wan-Long Chuang
The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies.
Gut 2007;56(5):736-7.
2007: J-F Huang; M-L Yu; Chuan-Mo Lee; Chia-Yen Dai; N-J Hou; M-Y Hsieh; Jing-Houng Wang; S-N Lu; I-S Sheen; S-M Lin; W-L Chuang; Yun-Fan Liaw
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
Alimentary pharmacology & therapeutics 2007;25(9):1029-37.
2007: Li-Po Lee; Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Nei-Jen Hou; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Tong-Jong Chen; Ming-Lung Yu
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients.
Journal of gastroenterology and hepatology 2007;22(4):515-7.
2007: Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Nei-Jen Hou; Li-Po Lee; Ming-Yen Hsieh; Chang-Fu Chiu; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C.
Gut 2007;56(4):553-9.
2007: Ming-Lung Yu; Chung-Feng Huang; Chia-Yen Dai; Jee-Fu Huang; Wan-Long Chuang
Long-term effects of interferon-based therapy for chronic hepatitis C.
Oncology 2007;72 Suppl 1():16-23.
2006: Chia-Yen Dai; Wan-Long Chuang; Nei-Jen Hou; Li-Po Lee; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Ming-Lung Yu
Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Clinical therapeutics 2006;28(12):2081-92.
2006: Ming-Lung Yu; Chia-Yen Dai; Li-Po Lee; Nei-Jen Hou; Ming-Yuh Hsieh; Jee-Fu Huang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(10):1187-95.
2006: Ming-Lung Yu; Shi-Ming Lin; Chuan-Mo Lee; Chia-Yen Dai; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Yun-Fan Liaw
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
Hepatology (Baltimore, Md.) 2006;44(5):1086-97.
2006: Chia-Yen Dai; W-L Chuang; Li-Po Lee; S-C Chen; N-J Hou; Z-Y Lin; M-Y Hsieh; M-Y Hsieh; L-Y Wang; W-Y Chang; M-L Yu
Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
Journal of viral hepatitis 2006;13(11):770-4.
2006: Chia-Yen Dai; Wan-Long Chuang; Ming-Yen Hsieh; Li-Po Lee; Nei-Jen Hou; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
Translational research : the journal of laboratory and clinical medicine 2006;148(3):128-33.
2006: Ming-Lung Yu; Wan-Long Chuang; Chia-Yen Dai; Li-Po Lee; Ming-Yuh Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Sun-Lung Tsai; Hsing-Tao Kuo
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Translational research : the journal of laboratory and clinical medicine 2006;148(3):120-7.
2006: Jee-Fu Huang; Wan-Long Chuang; Chia-Yen Dai; C-K Ho; Shang-Jyh Hwang; Shinn-Chern Chen; Z-Y Lin; L-Y Wang; Wen-Yu Chang; Ming-Lung Yu
Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
Journal of internal medicine 2006;260(3):255-62.
2006: Chun-Hao Chen; Chia-Yen Dai; Nai-Jen Hou; Shinn-Cherng Chen; Wan-Long Chuang; Ming-Lung Yu
Etiology, severity and recurrence of acute pancreatitis in southern taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi 2006;105(7):550-5.
2006: Jeng-Fu Yang; Chia-Yen Dai; Wan-Long Chuang; Wen-Yi Lin; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Ming-Lung Yu
Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C.
Japanese journal of infectious diseases 2006;59(1):25-30.
2006: Ming-Lung Yu; Chia-Yen Dai; Zu-Yau Lin; Li-Po Lee; Nei-Jen Hou; Ming-Yen Hsieh; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(1):73-81.
2006: Shyh-Shin Chiou; Jee-Fu Huang; Ting-Tsung Chang; Ming-Yuh Hsieh; Chia-Yen Dai; Ming-Lung Yu; Wen-Yu Chang; Wan-Long Chuang
SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
Digestion 2006;74(3-4):208-14.
2006: Ming-Lung Yu; Chia-Yen Dai; Li-Po Lee; Ming-Yen Hsieh; Nei-Jen Hou; Jee-Fu Huang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
Antiviral therapy 2006;11(8):1015-9.
2006: Ming-Lung Yu; Shi-Ming Lin; Wan-Long Chuang; Chia-Yen Dai; Jing-Houng Wang; Sheng-Nan Lu; I-Shyan Sheen; Wen-Yu Chang; Chuan-Mo Lee; Yun-Fan Liaw
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Antiviral therapy 2006;11(8):985-94.
2006: Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yuh Hsieh; Nei-Jen Hou; Zu-Yau Lin; Jee-Fu Huang; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
The Journal of infectious diseases 2006;193(1):98-101.
2006: Wang-Long Chuang; Ming-Lung Yu; Chia-Yen Dai; Wen-Yu Chang
Treatment of chronic hepatitis C in southern Taiwan.
Intervirology 2006;49(1-2):99-106.
2005: Ming-Lung Yu; Nai-Jen Hou; Chia-Yen Dai; Wen-Yu Chang; Wan-Long Chuang
Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirin.
Antimicrobial agents and chemotherapy 2005;49(9):3986-7.
2005: Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yuh Hsieh; Nei-Jen Hou; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
Antiviral research 2005;67(2):93-7.
2005: Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Ming-Hsing Sung; Ming-Yen Hsieh; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Ming-Lung Yu
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan.
The Journal of infection 2005;51(2):110-5.
2005: Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Nei-Jen Hou; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
World journal of gastroenterology : WJG 2005;11(27):4241-5.
2005: Jung-Fa Tsai; Jen-Eing Jeng; Lea-Yea Chuang; HL You; Liang-Yen Wang; Ming-Yuh Hsieh; Shinn-Cherng Chen; Wan-Long Chuang; Zu-Yau Lin; Ming-Lung Yu; Chia-Yen Dai
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Scandinavian journal of gastroenterology 2005;40(1):68-75.
2005: Ming-Lung Yu; Chia-Yen Dai; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Wan-Long Chuang
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.
BMC infectious diseases 2005;5():27.
2005: Wan-Long Chuang; Chia-Yen Dai; Wen-Yu Chang; Li-Po Lee; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Antiviral therapy 2005;10(1):125-33.
2004: Wan-Long Chuang; Chia-Yen Dai; Shinn-Cherng Chen; Li-Po Lee; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu; Wen-Yu Chang
Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(6):595-602.
2004: Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Zu-Yau Lin; Nei-Jen Hou; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Antiviral research 2004;64(1):47-53.
2004: Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang; Wen-Yu Chan
Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.
Digestive diseases and sciences 2004;49(7-8):1181-5.
2004: Ming-Lung Yu; Chia-Yen Dai; Shinn-Cherng Chen; Li-Po Lee; Jee-Fu Huang; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Wen-Yu Chang
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors.
Antiviral research 2004;63(1):25-32.
2004: Jung-Fa Tsai; Jen-Eing Jeng; Lea-Yea Chuang; Mei-Shang Ho; Ying-Chin Ko; Zu-Yau Lin; Ming-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai
Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis.
Medicine 2004;83(3):176-87.
2004: Chia-Yen Dai; Ming-Lung Yu; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang; Wen-Yu Chang
Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan.
Journal of clinical pathology 2004;57(2):141-5.
2003: Jung-Fa Tsai; Jen-Eing Jeng; Lea-Yea Chuang; HL You; Mei-Shang Ho; C S Lai; Liang-Yen Wang; Ming-Yuh Hsieh; Shinn-Cherng Chen; Wan-Long Chuang; Zu-Yau Lin; Ming-Lung Yu; Chia-Yen Dai
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(6):291-8.
2003: Jung-Fa Tsai; Jen-Eing Jeng; Lea-Yea Chuang; Mei-Shang Ho; Ying-Chin Ko; Zu-Yau Lin; Ming-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai; Chen Ho
Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study.
Medicine 2003;82(5):365-72.
2003: Ming-Lung Yu; Chia-Yen Dai; Shinn-Cherng Chen; Chao-Chin Chiu; Li-Po Lee; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Wen-Yu Chang
Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection.
The Journal of infectious diseases 2003;188(1):62-5.
2003: Ming-Lung Yu; Chia-Yen Dai; Chao-Chin Chiu; Li-Po Lee; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Chung-Jen Chen; Wan-Long Chuang; Wen-Yu Chang
Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha.
Antiviral research 2003;59(1):35-40.
2002: Chia-Yen Dai; Ming-Lung Yu; Cheng Hou; Sheng-Nan Lu; Jing-Houng Wang; Jee-Fu Huang; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Jung-Fa Tsai; Liang-Yen Wang; Wan-Long Chuang; Wen-Yu Chang
Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan).
Journal of gastroenterology and hepatology 2002;17(11):1192-7.
2002: Chia-Yen Dai; Ming-Lung Yu; Wen-Yu Chang; C H Tseng; Cheng Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang
The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan.
Epidemiology and infection 2002;129(2):307-13.
2002: Zu-Yau Lin; Wan-Long Chuang; Chia-Yen Dai; Ming-Lung Yu; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang
Clinical application of serum C-reactive protein measurement in the detection of bacterial infection in patients with liver cirrhosis.
The Kaohsiung journal of medical sciences 2002;18(3):121-6.
2002: Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang; Ming-Hsing Sung; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang
Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan.
Nephron 2002;90(2):148-53.
2002: Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang; Nei-Jen Hou; Cheng Hou; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang
The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients.
Antiviral research 2002;53(1):9-18.
2001: Ming-Lung Yu; Wan-Long Chuang; Chia-Yen Dai; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Jung-Fa Tsai; Liang-Yen Wang; Wen-Yu Chang
GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
Antiviral research 2001;52(3):241-9.
2001: Ming-Lung Yu; Wan-Long Chuang; Shinn-Chern Chen; Chia-Yen Dai; C Hou; Jing-Houng Wang; S N Lu; Jee-Fu Huang; Z Y Lin; Ming-Yuh Hsieh; J F Tsai; L Y Wang; Wen-Yu Chang
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.
Journal of medical virology 2001;65(1):58-65.
2001: Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang
Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection.
Journal of gastroenterology and hepatology 2001;16(6):636-40.
2001: Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang; C S Wang; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang
The molecular epidemiology and clinical significance of TT virus (TTV) infection in healthy blood donors from southern Taiwan.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2001;24(1):9-15.
2001: Ming-Lung Yu; Wan-Long Chuang; Chia-Yen Dai; Sheng-Nan Lu; Jing-Houng Wang; Jee-Fu Huang; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Jung-Fa Tsai; Liang-Yen Wang; Wen-Yu Chang
The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
The Journal of infection 2001;42(1):61-6.
2000: Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang; Sheng-Nan Lu; Jing-Houng Wang; Jee-Fu Huang; Cheng Hou; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang
The epidemiology of TT virus (TTV) infection in a hepatitis C and B virus hyperendemic area of southern Taiwan.
The Kaohsiung journal of medical sciences 2000;16(10):500-9.
2000: Ming-Lung Yu; Liang-Yen Wang; Wan-Long Chuang; Chia-Yen Dai; Ming-Hsing Sung; Shinn-Cherng Chen; Zu-Yau Lin; Ming-Yuh Hsieh; Jung-Fa Tsai; Wen-Yu Chang
Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis.
Journal of gastroenterology and hepatology 2000;15(7):792-7.